Medicskin Holdings Limited (8307.HK)
HKD 0.19
(0.0%)
HKD 0.19
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 9.5 Million | 3.24 Million | 4.29 Million | 9.14 Million | 14.91 Million | 4.21 Million |
| Net Income | -3.04 Million | -3.03 Million | 4.42 Million | 1.31 Million | -5.31 Million | -8.72 Million |
| Depreciation & Amortization | 9.39 Million | 9.32 Million | 9.73 Million | 9.81 Million | 10.45 Million | 4.59 Million |
| Deferred income taxes | - | - | - | -1.8 Million | 2.43 Million | 1.09 Million |
| Stock-based compensation | - | - | - | 26 Thousand | 205 Thousand | 502 Thousand |
| Change in working capital | 3.01 Million | -2.74 Million | -8.88 Million | -88 Thousand | 7.16 Million | 7.08 Million |
| Other non-cash items | 17.32 Million | -299 Thousand | -971 Thousand | -117 Thousand | -29 Thousand | -328 Thousand |
| Investing Cash Flow | -1.39 Million | -5.67 Million | -1.82 Million | -1.65 Million | 39.01 Million | -8.9 Million |
| Investments in PPE | -1.39 Million | -2.3 Million | -1.96 Million | -2.3 Million | -1.7 Million | -3.97 Million |
| Acquisitions | - | - | - | 213 Thousand | 40.15 Million | 4.58 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -365 Thousand | -3.37 Million | 145 Thousand | 439 Thousand | 569 Thousand | -9.5 Million |
| Financing Cash Flow | -7.21 Million | -6.73 Million | -17.94 Million | -21.03 Million | -27.22 Million | 2.63 Million |
| Debt repayment | -7.21 Million | -6.73 Million | -7.63 Million | -7.99 Million | -7.99 Million | - |
| Dividends payments | - | - | -9.91 Million | - | -19.42 Million | -721 Thousand |
| Common Stock Repurchased | - | - | - | -13.04 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | 2.82 Million |
| Other Financing Activities | -7.21 Million | -6.73 Million | -396 Thousand | -21.03 Million | 196 Thousand | 531 Thousand |
| Accounts receivables | 86 Thousand | -331 Thousand | 23 Thousand | 19 Thousand | 327 Thousand | -420 Thousand |
| Accounts payables | 992 Thousand | 7000.00 | -397 Thousand | 251 Thousand | -107 Thousand | 76 Thousand |
| Inventory | 527 Thousand | -2.16 Million | 143 Thousand | -203 Thousand | -8000.00 | -1.21 Million |
| Other working capital | 1.41 Million | -265 Thousand | -8.65 Million | -155 Thousand | 6.95 Million | 8.63 Million |
| Cash at beginning of period | 18.91 Million | 14.15 Million | 29.42 Million | 42.9 Million | 15.92 Million | 18.74 Million |
| Cash at end of period | 20.81 Million | 5 Million | 14.15 Million | 29.42 Million | 42.9 Million | 15.92 Million |
| Capital Expenditure | -1.39 Million | -2.3 Million | -1.96 Million | -2.3 Million | -1.7 Million | -3.97 Million |
| Effect of forex changes on cash | 18 Thousand | 10 Thousand | 204 Thousand | 57 Thousand | -65 Thousand | -427 Thousand |
| Net cash flow / Change in cash | 1.9 Million | -9.15 Million | -15.26 Million | -13.48 Million | 26.98 Million | -2.82 Million |
| Free Cash Flow | 8.11 Million | 946 Thousand | 2.32 Million | 6.84 Million | 13.2 Million | 235 Thousand |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -462.5 Thousand | -3.04 Million | -462.5 Thousand | -1.58 Million | -539 Thousand | -3.03 Million |
| Depreciation & Amortization | 2.31 Million | 9.39 Million | 2.31 Million | 4.75 Million | - | 9.32 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 113.5 Thousand | 3.01 Million | 113.5 Thousand | - | - | -2.74 Million |
| Other non-cash items | 1.87 Million | 17.32 Million | 1.87 Million | 1.58 Million | 539 Thousand | -299 Thousand |
| Investing Cash Flow | -372.5 Thousand | -1.39 Million | -372.5 Thousand | -621 Thousand | - | -5.67 Million |
| Investments in PPE | -388 Thousand | -1.39 Million | -388 Thousand | -621 Thousand | - | -2.3 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 15.5 Thousand | -365 Thousand | 15.5 Thousand | - | - | -3.37 Million |
| Financing Cash Flow | -1.68 Million | -7.21 Million | -1.68 Million | -3.85 Million | - | -6.73 Million |
| Debt repayment | - | -7.21 Million | - | - | - | -6.73 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.68 Million | - | -1.68 Million | - | - | -6.73 Million |
| Accounts receivables | 43 Thousand | 86 Thousand | 43 Thousand | - | - | -331 Thousand |
| Accounts payables | - | 992 Thousand | - | - | - | 7000.00 |
| Inventory | 263.5 Thousand | 527 Thousand | 263.5 Thousand | - | - | -2.16 Million |
| Other working capital | -193 Thousand | 1.41 Million | -193 Thousand | - | - | -265 Thousand |
| Cash at beginning of period | 16.95 Million | 18.91 Million | - | 18.91 Million | - | 14.15 Million |
| Cash at end of period | 20.81 Million | 20.81 Million | 1.78 Million | 16.95 Million | - | 5 Million |
| Capital Expenditure | -388 Thousand | -1.39 Million | -388 Thousand | -621 Thousand | - | -2.3 Million |
| Effect of forex changes on cash | -2000.00 | 18 Thousand | -2000.00 | -410 Thousand | - | 10 Thousand |
| Net cash flow / Change in cash | 3.86 Million | 1.9 Million | 1.78 Million | -1.95 Million | - | -9.15 Million |
| Free Cash Flow | 3.45 Million | 8.11 Million | 3.45 Million | 2.3 Million | - | 946 Thousand |
CLS
ACGLO
0HYP
NDTAF
0A52
NWUC